MYLAN 8030 MYLAN 8030 (Lansoprazole delayed release 30 mg)

Pill imprint MYLAN 8030 MYLAN 8030 has been identified as Lansoprazole delayed release 30 mg.

Lansoprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; duodenal ulcer; zollinger-ellison syndrome (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for MYLAN 8030 MYLAN 8030

Lansoprazole delayed release 30 mg MYLAN 8030 MYLAN 8030
Lansoprazole delayed release
Imprint:
MYLAN 8030
MYLAN 8030
Strength:
30 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-8030
Inactive Ingredients:
silicon dioxide
corn starch
hydroxypropyl cellulose
low substituted hydroxypropyl cellulose
magnesium carbonate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol
polysorbate 80
sucrose
magnesium silicate
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3
gelatin
propylene glycol
shellac
ferrosoferric oxide
potassium hydroxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0121 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)